3Reisine T. Molecular propenties of somatostatin receptors. Neuroscience, 1995,67: 779 - 790.
4Argyropoulos SV, Nutt DJ. Substance P antagonists: novel agents in the treatment of depression. Expert Opin Investig Drugs, 2000, 9(8) : 1871 - 5. Review.
5Cohen G, Gressens P. Depression of hypoxic arousal response in adolescent mice following antenatal VIP. J physiol, 2002, 540(2) :691 - 699.
6Fu Croll SD, Chesnutt CR, Greene NA, et al. Peptide immunoreactivity in aged rat cortex and hippoeampus as a notion of memory and BDNF infusion. Pharmacol Biochem Behav, 1999,64(3) :625 - 35.
7Vezzani A, Michalklewicz M, Michalkiewicz T. Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience, 2002,110(2) : 237 -43.
